Latest 10-K annual reports

Bitcoin Depot Inc. files an amendment to its 2024 annual report to include the company's clawback policy and insider trading policy as exhibits.

Entero Therapeutics reports ongoing losses and explores strategic alternatives, including a potential rescission agreement with ImmunogenX, raising concerns about its ability to continue as a going concern.

Movano Inc. amends its office lease for rent forbearance and extends the lease term, while the 2024 10-K filing reveals ongoing financial losses and efforts to secure additional funding for its Evie Ring and EvieMED products.

Seafarer Exploration Corp. files an amendment to its 10-K report, highlighting ongoing financial losses, substantial debt, and material weaknesses in internal controls, raising concerns about the company's ability to continue as a going concern.

Athena Gold Corporation files its Form 10-K, detailing its financial results for the year ended December 31, 2024, and outlining its ongoing exploration activities and corporate strategies, including a planned redomestication to British Columbia.

Momentus Inc. has filed an amendment to its 2024 Annual Report on Form 10-K to revise the exhibit index and include the consent of Frank, Rimerman + Co. LLP, the independent registered public accounting firm.

Lottery.com Inc. details its challenging fiscal year 2023 in an amended annual report, outlining efforts to resume operations and secure funding following a significant operational cessation, while grappling with substantial losses, material weaknesses, and legal proceedings.

Eco Bright Future Inc. reports its financial results for the year ended December 31, 2024, outlining its strategic focus on blockchain technology, real-world asset tokenization, and expansion into international markets.

FutureTech II Acquisition Corp.'s 10-K filing outlines the company's share structure, warrant details, and ongoing efforts to complete a business combination, including a merger agreement with Longevity Biomedical Inc.

Patriot Gold Corp.'s 2024 financial results reveal a net loss driven by decreased royalty revenue and increased expenses, compounded by a legal dispute impacting future royalty payments.

Totaligent, Inc. files an amendment to its 2024 annual report to correct certain items and expand disclosures in the Subsequent Events section.

American Rebel Holdings, Inc. reports $11.4 million in revenue for 2024 while navigating strategic shifts, debt financing, and compliance with Nasdaq listing requirements.

Greenpro Capital Corp.'s 2024 annual report highlights a strategic shift towards digital assets and expansion in Southeast Asia, amidst ongoing financial challenges.

UScellular files an amendment to its 2024 Annual Report on Form 10-K to include information required by Part III, Items 10 through 14, related to directors, executive officers, compensation, security ownership, related transactions, and accountant fees.

Digital Brands Group's 10-K filing details the company's capital stock structure, recent financial activities, and risk factors affecting its business.

Aclarion's 2024 10-K filing highlights its ongoing efforts to commercialize its NOCISCAN technology, secure payer contracts, and expand strategic relationships within the low back pain market.

Blink Charging's FY24 results reveal a revenue decrease alongside strategic shifts and the identification of material weaknesses in internal controls.

Royale Energy's 2024 results reveal a net loss, increased oil production, and strategic financial maneuvers amidst evolving regulatory challenges.

Reliance Global Group files an amendment to its annual report on Form 10-K to include its Compensation Recovery Policy (Clawback Policy) as an exhibit.

Glen Burnie Bancorp experienced a net loss of $0.1 million in 2024, a significant downturn compared to the $1.4 million net income in 2023, primarily due to decreased net interest income and increased expenses.

Hepion Pharmaceuticals reports its 2024 financial results, highlighting a strategic restructuring, termination of a merger agreement, and substantial doubt about its ability to continue as a going concern.

Jingbo Technology files an amended 10-K, restating prior financials and highlighting concerns about its ability to continue as a going concern.

Gold Resource Corporation's 2024 10-K filing reveals substantial doubt about the company's ability to continue as a going concern due to production declines, equipment issues, and insufficient liquidity.

Capstone Companies, Inc. files an amendment to its 2024 annual report to correct minor typographical errors and update exhibit information.

BioLife Solutions has filed an amendment to its 2024 Annual Report to restate Part III, covering directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, director independence, and principal accounting fees, and to file new certifications.

Mama's Creations, Inc. reports a 19% increase in net sales for the year ended January 31, 2025, but acknowledges challenges related to manufacturing inefficiencies and rising commodity costs.

BioForce Nanosciences Holdings reports no revenue for FY 2024, a net loss of $490,437, and expresses substantial doubt about its ability to continue as a going concern.

Ocean Biomedical, Inc. files its annual report on Form 10-K, detailing its financial results for the year ended December 31, 2024, and providing an update on its preclinical development programs.

Ameritek Ventures, Inc. reports a significant increase in net income for 2024, driven by a gain on asset disposal from the sale of Ecker Capital to ZenaTech, despite a decrease in operating revenue.

The Dixie Group's 2024 10-K filing reveals delisting from Nasdaq, increased net losses, and concerns about meeting financial covenants despite a new credit facility.